| Application no. and date | 18800871.8 (espacenet) (Federated) (European Patent Register), 20181101 | | Patent/reg. no. and date | DK/EP 3703747, 20250903 | | Publication date | 20200909 | | Priority no. and date | EP 17199601, 20171101 | | EP pub. no. and date |
EP 3703747 20200909 | | Effective date | | | Applicant/owner | University Of Southampton, University Road
Southampton, Hampshire SO17 1BJ, GB,
Calliditas Therapeutics Suisse SA, chemin des Aulx 14
1228 Plan-les-Ouates, CH | | Applicant ref. no. | CALQ/P89105EP | | Inventor | HEITZ, Freddy, Chemin de champ-Fleury 4
1233 Bernex, CH,
WIESEL, Philippe, 11 rue Juliette Lamber
75017 Paris, FR,
THOMAS, Gareth, Bisterne Lodge
Bisterne Close
Burley
Hampshire BH24 4BA, GB,
HANLEY, Christopher, 7 Marchwood Road
Southampton
Hampshire SO15 8AN, GB,
FORD, Kirsty, 10 Dale Avenue
Weymouth
Dorset DT47RB, GB | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 4. tv., 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) | | Title | USE OF A NOX4 OR NOX4/1 INHIBITOR IN COMBINATION WITH AN IMMUNOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER | | Int. application no. | EP2018079945 | | Int. publication no. | WO2019086579 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
